Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery

17Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We examined the effects of lomerizine on serotonin (5-hydroxytryptamine, 5-HT)-induced contraction of the basilar artery and compared them with those of nifedipine. Although both lomerizine and nifedipine completely blocked K +-induced vasoconstriction, 5-HT-induced vasoconstriction was more strongly inhibited by lomerizine than nifedipine. A 5-HT2A antagonist inhibited the 5-HT-induced vasoconstriction, but a 5-HT1B antagonist did not. Lomerizine, but not nifedipine, suppressed 5-HT-induced Ca 2+ release in 5-HT2A-expressing HEK293 cells. Moreover, neither antagonist affected ATP-induced Ca2+ release. These results suggest that lomerizine may inhibit not only voltage-dependent Ca2+ channels but also 5-HT2A receptors and so inhibit 5-HT-induced contraction in the basilar artery. ©2009 The Japanese Pharmacological Society.

Cite

CITATION STYLE

APA

Ishii, M., Kobayashi, S., Ohkura, M., Yamamoto, R., Shimizu, S., & Kiuchi, Y. (2009). Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery. Journal of Pharmacological Sciences, 111(2), 221–225. https://doi.org/10.1254/jphs.09205SC

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free